文献速递角膜与眼表疾病

热电温热疗法治疗睑板腺功能障碍的疗效

Effect of Thermoelectric Warming Therapy for the Treatment of Meibomian Gland Dysfunction.
PubMed 文献 · Am J Ophthalmol · 2022-06-25

回顾性治疗前后研究纳入102例干眼病患者的203只眼,接受MiBoFlo热电温热治疗,6个月后SPEED与OSDI干眼症状评分均降低约35%(P < .001),结膜丽丝胺绿染色、角膜荧光素染色、泪膜破裂时间、渗透压、分泌睑板腺数量及睑脂质量均显著改善;伴睑缘炎和自身免疫病者改善低于平均水平,无并发症或不良事件。

要点

  • MiBoFlo治疗后6个月SPEED与OSDI症状评分均降低约35%(P < .001)。
  • 结膜丽丝胺绿染色、角膜荧光素染色、泪膜破裂时间、渗透压、分泌睑板腺数量及睑脂质量均显著改善。
  • 伴睑缘炎和自身免疫病者改善低于平均水平,无并发症或不良事件。

核心结论

  • MiBoFlo治疗使睑板腺功能障碍的体征和症状获得临床和统计学显著改善,且不依赖于基础眼部情况,改善在开始治疗后6个月观察期内持续存在。

研究设计与样本

  • 回顾性治疗前后研究,共纳入干眼病患者的203只眼(102例患者),在干眼中心接受MiBoFlo治疗。
  • 排除标准包括活动性眼部炎症。

主要发现

  • 治疗后6个月,SPEED与OSDI干眼症状评分均降低约35%(P < .001)。
  • 结膜丽丝胺绿染色、角膜荧光素染色、泪膜破裂时间、渗透压、分泌睑板腺数量及睑脂质量均显著改善。
  • 问卷所有领域及所有基线参数均见改善。
  • 伴睑缘炎和自身免疫病的眼改善低于平均水平。
  • 未发生并发症或不良事件。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the efficacy of thermoelectric warming therapy (MiBoFlo) in improving patient symptoms with standardized questionnaires and objective signs of meibomian gland dysfunction (MGD), which is an important underlying treatable factor in dry eye disease (DED), such as ocular surface staining, tear quality, and meibomian gland morphology. Multivariate analysis to identify predictors for the improvement in Ocular Surface Disease Index (OSDI) was also performed. DESIGN: Retrospective before-and-after study. METHODS: A total of 203 eyes of 102 patients with DED were treated with MiBoFlo at the dry eye center. The OSDI and Standard Patient Evaluation of Eye Dryness (SPEED) questionnaires, best-corrected visual acuity, tear osmolarity, tear film breakup time (TBUT), corneal and conjunctival staining, meibography, number of glands expressing liquid, and quality of the improved meibum were assessed before and 6 months after MiBoFlo. Exclusion criteria included active ocular inflammation. RESULTS: Dry eye symptoms improved in the population, with both SPEED and OSDI lowering of dry eye symptoms by approximately 35% (P < .001) at month 6. Significant improvements in lissamine green conjunctival staining, corneal fluorescein staining, TBUT, osmolarity, and secreting meibomian glands and meibum quality were also seen. Improvement was seen across all domains of the questionnaires and across all baseline parameters. Eyes with blepharitis and autoimmune disease improved less than average. No complications or adverse events occurred. CONCLUSIONS: MiBoFlo treatments produced clinical and statistically significant improvements in the signs and symptoms of MGD, irrespective of underlying ocular conditions. This improvement was sustained for the 6-month period of observation after initiating the treatment.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Gomez ML, Afshari NA, Gonzalez DD, et al. Effect of Thermoelectric Warming Therapy for the Treatment of Meibomian Gland Dysfunction. Am J Ophthalmol. 2022. PMID: 35764104. doi:10.1016/j.ajo.2022.06.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。